Journal for ImmunoTherapy of Cancer · 2019 · 28 citations · 22 references
MedicineCancer BiologyOncologyMolecular OncologyTranscriptional RegulationTumor ProgressionBiomarkers In Urologic OncologyImmuno-oncology BiomarkersKidney CancerMacrophage BiologyRenal Cell CarcinomaTumor-associated MacrophagesCancer-associated MacrophagesDisease-free Survival AnalysisDisease-free Survival AssessmentMacrophage BiomarkersPatient Outcome PredictionProtein Expression BiomarkersRenal Cell Carcinoma BiomarkersTumor-associated Cytokines
Tumor-associated macrophages have been well-characterized in solid malignancies, including renal cell carcinoma and generally correlate with poor prognosis. However, the molecular mechanisms which govern intratumoral macrophage behavior and patient outcome are unclear. Here, we investigated whether alterations in macrophage expression of the transcriptional regulator for myeloid commitment and function, interferon regulatory factor-8 (IRF8), could predict survival of clear cell renal cell carcinoma patients. Transcriptional analysis of publicly available data revealed elevated IRF8 expression was associated with prolonged disease-free survival. Evaluation of protein expression within histologic sections of primary clear cell renal cell carcinoma patient samples showed intensity of IRF8 by CD68<sup>+</sup> macrophages correlated inversely with stage. Survival outcomes of patients with primary or metastatic disease could be stratified on the basis of IRF8 levels by macrophages. Patients with high levels of IRF8 expression within metastatic sites had prolonged overall survival (log-rank <i>P</i> < 0.01, HR = 0.44, 95% C.I.: 0.23–0.84) compared to patients with low levels of IRF8 expression. When patient cohorts were further separated based on macrophage infiltration within metastatic lesions, patients with a macrophage<sup>lo</sup> IRF8<sup>hi</sup> profile had a more than 10 year increase in median overall survival compared to patients with a macrophage<sup>lo</sup> IRF8<sup>lo</sup> profile (log-rank, <i>P <</i> 0.001). In summary, we report that macrophage expression of IRF8 is inversely correlated with tumor mass and directly related to survival outcome. These findings support the utilization of IRF8 expression by macrophages to predict patient outcome, which may have important implications for guiding treatment decisions for renal cell carcinoma patients with metastatic disease.
22
Robust enumeration of cell subsets from tissue expression profiles
Aaron M. Newman, Chih Long Liu, Michael R. Green et al. · Nature Methods · 2015 · 14.1K citations · Full text
The Immune Landscape of Cancer
Vésteinn Thórsson, David L. Gibbs, Scott D. Brown et al. · Immunity · 2018 · 6.2K citations · Full text
Medicine, Immunology, Oncology +17
Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer
Gabriela Bindea, Bernhard Mlecnik, Marie Tosolini et al. · Immunity · 2013 · 4.7K citations · Full text
Medicine, Immunology, Oncology +17
Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity
Michael S. Rooney, Sachet A. Shukla, Catherine J. Wu et al. · Cell · 2015 · 4.1K citations · Full text
Medicine, Immunology, Oncology +17
Yasin Şenbabaoğlu, Ron S. Gejman, Andrew Winer et al. · Genome biology · 2016 · 1K citations · Full text
Medicine, Immunology, Oncology +17